Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status.
about
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Low-burden TP53 mutations in c ...... pe and JAK2 mutational status.
@en
Low-burden TP53 mutations in c ...... pe and JAK2 mutational status.
@nl
type
label
Low-burden TP53 mutations in c ...... pe and JAK2 mutational status.
@en
Low-burden TP53 mutations in c ...... pe and JAK2 mutational status.
@nl
prefLabel
Low-burden TP53 mutations in c ...... pe and JAK2 mutational status.
@en
Low-burden TP53 mutations in c ...... pe and JAK2 mutational status.
@nl
P2093
P2860
P356
P1433
P1476
Low-burden TP53 mutations in c ...... pe and JAK2 mutational status.
@en
P2093
B Gisslinger
B Kantorova
B Kubesova
H Gisslinger
J Kabathova
J Malcikova
K Fiedorova
P2860
P2888
P304
P356
10.1038/LEU.2017.230
P577
2017-07-24T00:00:00Z
P6179
1090879278